Observational studyAnnals of African medicine2026
Mind Over Matter: Cognitive Decline in Hemodialysis Patients: A Cross-sectional Analysis.
Observational study in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChronic kidney disease (CKD) affects up to 15% of the global population, with cognitive impairment frequently reported in patients, particularly those undergoing hemodialysis (HD). The study aims to analyze cognitive performance differences between patients receiving conservative management and those on HD in India. MATERIALS AND
methodsThis observational cross-sectional study was conducted between September 2021 and April 2023, involving 1214 end-stage CKD patients - 604 on conservative therapy and 610 on HD. Neurocognitive assessment tools included the abbreviated mini-mental state examination (MMSE), Addenbrooke's cognitive examination III (ACE-III), Grober and Buschke Test, Trail Making Tests, Stroop Test, and Boston Naming Test. Statistical analysis utilized the Wilcoxon and Chi-square tests for group comparisons.
resultsThe HD group demonstrated significantly lower scores in the ACE-III visuospatial domain ( P = 0.00685) and verbal inhibitory control ( P = 0.011) assessed by the INECO frontal screening test. No significant differences were observed in global cognitive performance based on MMSE or other ACE-III domains. In addition, 16.7% of HD patients had deficient Stroop test scores, and 33.3% were unable to complete it due to visual difficulties. DISCUSSION: The findings highlight selective deficits in frontal-executive functions among HD patients, potentially reflecting subcortical and vascular pathophysiology due to hemodynamic stress and cerebral hypoperfusion. These results underscore the need for routine cognitive screening in CKD patients to guide treatment strategies.
conclusionPatients with end-stage CKD on HD exhibited significant impairments in executive function compared to those under conservative management. Incorporating neurocognitive evaluations into clinical practice can enhance treatment decision-making and improve patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.